Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
* Total revenues increased by 50% to 19.7 million euro (2004: 13.1 million euro) * Operating loss (EBIT) reduced by 22% to -11.5 million euro...
MARTINSRIED, Germany and SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- The Executive Board of the German-American biotech company MediGene AG...
- MediGene Receives Milestone Payment for Launch in France - MediGene's First Drug* Now Available in 11 European Countries MARTINSRIED, Germany...
MARTINSRIED/MUNICH, Germany and SAN DIEGO, Feb. 14 /PRNewswire-FirstCall/ -- The German-American biotech company MediGene AG (German Stock...
* Bradley acquires US commercialization rights for genital warts and other dermatological diseases. MediGene retains full rest of world...
* A non-exclusive license under existing tumor-vaccine patents MARTINSRIED, Germany and MUNICH, Germany, and SAN DIEGO, Dec. 19...
MARTINSRIED and MUNICH, Germany and SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- The German-American biotech company MediGene AG (Frankfurt...
* Total revenues of 8.6 million euro (9M-2004: 11.5 million euro) MARTINSRIED/MUNICH, Germany and SAN DIEGO, Nov. 2 /PRNewswire-FirstCall/...
MARTINSRIED, Germany and SAN DIEGO, Aug. 24 /PRNewswire-FirstCall/ -- Today the German-American biotech company MediGene AG (Frankfurt, Prime...
* Total revenues of 4.9 million euro (H1-2004: 8.8 million euro) * Net loss -6.3 million euro (H1-2004: -4.2 million euro) * Operational cash flow...
MediGene to Present at Fourth Annual Needham Biotechnology Conference in New York City MARTINSRIED/MUNICH, Germany and SAN DIEGO, May 23...
Again MediGene AG Significantly Improves Quarterly Result * Net loss -0.9 million EUR (Q1-2004: -1.5 million EUR) * Total revenues 3.8 million EUR...
MediGene Announces Webcast of Analyst Conference and Conference Call of 2004 Year End Results Analyst Conference to be Held on March 23 in...
MediGene to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference MARTINSRIED, Germany and SAN DIEGO, Oct. 22...
MediGene Initiates Clinical Phase I/II Trial of Cancer-Killing Virus NV1020 for the Treatment of Liver Metastases MARTINSRIED, Germany and SAN...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관